Butylamine → 5,6-Dimethyl-2-butylamino4-(1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine hydrochloride
Reaction equation
[CH2:1]([NH2:5])[CH2:2][CH2:3][CH3:4].C(N(CC)CC)C.[Cl:13][C:14]1[N:19]=[C:18]([N:20]2[CH2:29][CH2:28][C:27]3[C:22](=[CH:23][CH:24]=[CH:25][CH:26]=3)[CH2:21]2)[C:17]([CH3:30])=[C:16]([CH3:31])[N:15]=1>CN(C)C=O>[ClH:13].[CH3:30][C:17]1[C:18]([N:20]2[CH2:29][CH2:28][C:27]3[C:22](=[CH:23][CH:24]=[CH:25][CH:26]=3)[CH2:21]2)=[N:19][C:14]([NH:5][CH2:1][CH2:2][CH2:3][CH3:4])=[N:15][C:16]=1[CH3:31]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
After butylamine(0.53 ml, 5.4 mmol) and triethylamine(0.38 ml, 2.7 mmol) were added to a solution of 2-chloro-5,6-dimethyl-4-(1,2,3,4-tetrahydroisoquinolin-2-yl) pyrimidine(0.5 g, 1.8 mmol) in dimethylformamide, 300 mg of the titled compound was obtained in accordance with the same procedure as in Example 1.
Sources & evidence
- ORD record
- ord-3ea3bf6fff914ff98ea88996a0e0cb2d
- Source dataset
- uspto-grants-2002_03
- Patent number
- US06352993B1
Reaction notes
Loading…